CD44 and cancer: Further, we found that mebendazole (MBZ), a benzimidazole derivative, exhibited the most effective anticancer effects in TNBC through inducing DNA damage, cell cycle arrest, and downregulating cancer stem cell markers CD44 and OCT3/4 and cancer progression-related ESM-1 protein expression [9].